CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful

This story has been updated to add a statement from Abbott on the study.

NEW YORK – The US Centers for Disease Control and Prevention published on Tuesday an evaluation of Abbott's SARS-CoV-2 BinaxNow rapid antigen test, finding that the test is less sensitive than PCR but could be particularly useful when PCR tests aren't available or when quick turnaround times are needed.